Immuno-Biological Laboratories, Intellect Neurosciences deal

Immuno-Biological granted Intellect exclusive rights to develop, manufacture and commercialize two beta amyloid-specific, humanized MAbs to treat Alzheimer's disease (AD). Intellect hopes to begin Pha...